China's COVID-19 vaccination program may be expanded to include low age groups of minor and young people aged 3 to 17 years old, domestic news site yicai.com reported.
Yang Xiaoming, chairman of China National Biotec Group (CNBG), a leading COVID-19 vaccine developer, said his company is submitting relevant clinical data to the National Medical Products Administration.
It is expected that children and teenagers will be cleared to be vaccinated as early as March, Yang said.
Yang said this low age group can be vaccinated, based on internal data, but stressed that more caution must be exercised and more observation is needed.
Children's immune system differs to that from adults, being less developed.
CNBG is a subsidiary of China's pharmaceutical company Sinopharm, who's vaccine product has already been administered to 10 million recipients.
